CD19 and hepatocellular carcinoma: Additionally, in the current study, we showed that the B-cell depletion therapy and protective therapeutic vaccination (combination) therapy led to a reduction in the number of the CD19-B220+CD5+CD1d- Breg subset, as well as in the level of IL-10 expression on these cells, and improved survival in mice harboring HCC.